BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19126434)

  • 1. Biology of endocannabinoid synthesis system.
    Wang J; Ueda N
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):112-9. PubMed ID: 19126434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthetic pathways of the endocannabinoid anandamide.
    Okamoto Y; Wang J; Morishita J; Ueda N
    Chem Biodivers; 2007 Aug; 4(8):1842-57. PubMed ID: 17712822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic formation of anandamide.
    Okamoto Y; Tsuboi K; Ueda N
    Vitam Horm; 2009; 81():1-24. PubMed ID: 19647106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
    Ueda N; Tsuboi K; Uyama T; Ohnishi T
    Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Ueda N; Tsuboi K; Uyama T
    Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules.
    Egertová M; Simon GM; Cravatt BF; Elphick MR
    J Comp Neurol; 2008 Feb; 506(4):604-15. PubMed ID: 18067139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into endocannabinoid degradation and its therapeutic potential.
    Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
    Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid metabolic pathways and enzymes.
    Ligresti A; Cascio MG; Di Marzo V
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical enzymes involved in endocannabinoid metabolism.
    Basavarajappa BS
    Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals.
    Nyilas R; Dudok B; Urbán GM; Mackie K; Watanabe M; Cravatt BF; Freund TF; Katona I
    J Neurosci; 2008 Jan; 28(5):1058-63. PubMed ID: 18234884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.
    Di Marzo V
    Nat Neurosci; 2011 Jan; 14(1):9-15. PubMed ID: 21187849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines.
    Ueda N; Okamoto Y; Morishita J
    Life Sci; 2005 Aug; 77(14):1750-8. PubMed ID: 15949819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.
    Ueda N; Okamoto Y; Tsuboi K
    Curr Med Chem; 2005; 12(12):1413-22. PubMed ID: 15974992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New players in the fatty acyl ethanolamide metabolism.
    Rahman IA; Tsuboi K; Uyama T; Ueda N
    Pharmacol Res; 2014 Aug; 86():1-10. PubMed ID: 24747663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
    Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
    Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.
    Tsuboi K; Okamoto Y; Ikematsu N; Inoue M; Shimizu Y; Uyama T; Wang J; Deutsch DG; Burns MP; Ulloa NM; Tokumura A; Ueda N
    Biochim Biophys Acta; 2011 Oct; 1811(10):565-77. PubMed ID: 21801852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.